Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RETROSPECTIVE AND PROSPECTIVE MULTICENTER STUDY EVALUATING LONG TERM EFFECTIVENESS AND SAFETY OF CABOTEGRAVIR AND RILPIVIRINE IN REAL LIFE AS A LONG-ACTING TREATMENT IN PEOPLE LIVING WITH HIV AFTER ITS IMPLEMENTATION IN SPAIN. RELATIVITY COHORT

NCT07703748 is registered in ClinicalTrials.gov with FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE as lead sponsor.

NCT NCT07703748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07703748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RETROSPECTIVE AND PROSPECTIVE MULTICENTER STUDY EVALUATING LONG TERM EFFECTIVENESS AND SAFETY OF CABOTEGRAVIR AND RILPIVIRINE IN REAL LIFE AS A LONG-ACTING TREATMENT IN PEOPLE LIVING WITH HIV AFTER ITS IMPLEMENTATION IN SPAIN. RELATIVITY COHORT
Lead sponsor
FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE
Phase
Observational
Overall status
Active, not recruiting
Start date
December 31, 2024
Completion date
April 30, 2029
Enrollment
3,346 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1 infection in adults, human immunodeficiency virus infection (hiv)